Nu-Med Plus (NUMD) Return on Capital Employed Growth (3y) (2016 - 2025)
Nu-Med Plus (NUMD) Return on Capital Employed Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -16,203.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16,203.00 |
| Sep 30, 2025 | -8,885.00 |
| Jun 30, 2025 | -11,838.00 |
| Mar 31, 2025 | -27,179.00 |
| Dec 31, 2024 | -68,320.00 |
| Sep 30, 2024 | -235,950.00 |
| Jun 30, 2024 | 168,154.00 |
| Mar 31, 2024 | 72,748.00 |
| Dec 31, 2023 | 46,689.00 |
| Sep 30, 2023 | 58,003.00 |
| Jun 30, 2023 | 783,988.00 |
| Mar 31, 2023 | -2,367.00 |
| Dec 31, 2022 | -11,500.00 |
| Sep 30, 2022 | -25,286.00 |
| Jun 30, 2022 | -45,412.00 |
| Mar 31, 2022 | -130,615.00 |
| Dec 31, 2021 | 174,503.00 |
| Sep 30, 2021 | 349,646.00 |
| Jun 30, 2021 | -407,054.00 |
| Mar 31, 2021 | 124,638.00 |